At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,250 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Patellar Crepitus Following PFC Sigma vs. PFC Sigma HP Total Knee Arthroplasty: Does Femoral Component Design Make a Difference?
In Brief
An observational study for Total Knee Replacement. Completed, enrolled 1,250 participants.
Detailed Summary
Analyze clinical data for a group of subjects implanted with a new surgical device designed to reduce the incidence of patellar crepitus following PCL-substituting TKA and compare that to a control group of subjects implanted with a TKA design known to have an incidence of patellar crepitus of approximately 5%.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTotal Knee Replacement
Countries--
CollaboratorsDePuy Orthopaedics
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedApr 2011
Primary CompletionJun 2014
Study CompletionSep 2014
TodayJul 2026
First PostedApr 22, 2011
Enrollment StartApr 1, 2011
Primary CompletionJun 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 15.2 years ago